Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...

Privately-held Italian drugmaker Angelini Pharma has breached the Code of Practice for the Association of the British ...

Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...

Germany’s Bayer has announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian.

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...

Switzerland is becoming the benchmark for American drug prices, warns the trade body Interpharma. A new US model links ...

The US Food and Drug Administration (FDA) has approved Padcev (enfortumab vedotin-ejfv), a nectin-4 directed antibody-drug ...

A technology-driven drug discovery company that integrates large-scale human data and artificial intelligence through its ...

Swiss biosimilars and generics company Sandoz today announced the European launch of Afqlir (aflibercept), a 2 mg vial kit ...

Australian drugmaker Mayne Pharma last week revealed it has been notified by USA-based Cosette Pharmaceuticals that it had ...

Last week Dutch firm Merus inked a deal with USA-based Halozyme for the latter’s ENHANZE technology to deliver cancer ...